[Pharmacokinetics and results of clinical administration of CS-1170. II. Results of clinical administration of CS-1170 (author's transl)]. 1979

K Cho, and M Takimoto, and H Yoshioka, and H Nanbu

The intravenous preparation of CS-1170 was administered in 9 cases of pediatric disease and was excellent or good in 5 cases (55.6%). It was poor in 3 of 4 cases of Mycoplasma pneumonia. We think that the dose of 50 mg/kg/day can exert an effect regardless of the intensity of symptoms. Through our present experiences with the excellent or good cases, an intravenous drip or intratracheal injection for 3 approximately 5 days is effective. Although there was no abnormality in the biochemistry or electrolyte findings before or after administration, eruption developed in one of the cases in which the drug was administered for 6 days.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002513 Cephamycins Naturally occurring family of beta-lactam cephalosporin-type antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms. Antibiotics, Cephamycin,Cephamycin,Cephamycin Antibiotics
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K Cho, and M Takimoto, and H Yoshioka, and H Nanbu
February 1979, The Japanese journal of antibiotics,
K Cho, and M Takimoto, and H Yoshioka, and H Nanbu
March 1979, The Japanese journal of antibiotics,
K Cho, and M Takimoto, and H Yoshioka, and H Nanbu
January 1979, The Japanese journal of antibiotics,
K Cho, and M Takimoto, and H Yoshioka, and H Nanbu
March 1979, The Japanese journal of antibiotics,
K Cho, and M Takimoto, and H Yoshioka, and H Nanbu
February 1979, The Japanese journal of antibiotics,
K Cho, and M Takimoto, and H Yoshioka, and H Nanbu
February 1979, The Japanese journal of antibiotics,
K Cho, and M Takimoto, and H Yoshioka, and H Nanbu
January 1979, The Japanese journal of antibiotics,
K Cho, and M Takimoto, and H Yoshioka, and H Nanbu
February 1979, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
K Cho, and M Takimoto, and H Yoshioka, and H Nanbu
February 1979, The Japanese journal of antibiotics,
K Cho, and M Takimoto, and H Yoshioka, and H Nanbu
January 1979, The Japanese journal of antibiotics,
Copied contents to your clipboard!